Serveur d'exploration COVID et hydrochloroquine - Exploration (Accueil)

Index « AbsEn.i » - entrée « importantly »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
important < importantly < importation  Facettes :

List of bibliographic references indexed by importantly

Number of relevant bibliographic references: 8.
Ident.Authors (with country if any)Title
000105 (2021) Nour K. Younis [Liban] ; Rana O. Zareef [Liban] ; Mohammad Ali N. Maktabi [Liban] ; Rami Mahfouz [Liban]The Era of the Coronavirus Disease 2019 Pandemic: A Review on Dynamics, Clinical Symptoms and Complications, Diagnosis, and Treatment.
000161 (2021) Eric Prommer [États-Unis]Safety and Utility of Chloroquine/ Hydroxychloroquine in Palliative Care Patients.
000303 (2021) Jun Chen [République populaire de Chine] ; Hongzhou Lu [République populaire de Chine]New challenges to fighting COVID-19: Virus variants, potential vaccines, and development of antivirals.
000B74 (2020) Anne-Lise Bienvenu [France] ; Aileen M. Marty [États-Unis] ; Malcolm K. Jones [Australie] ; Stephane Picot [France]Systematic review of registered trials of Hydroxychloroquine prophylaxis for COVID-19 health-care workers at the first third of 2020.
000D39 (2020) Santosh Kumar [États-Unis] ; Kaining Zhi [États-Unis] ; Ahona Mukherji [États-Unis] ; Kelli Gerth [États-Unis]Repurposing Antiviral Protease Inhibitors Using Extracellular Vesicles for Potential Therapy of COVID-19.
001150 (2020) Huiying Xue [République populaire de Chine] ; Yi Liu [République populaire de Chine] ; Pan Luo [République populaire de Chine] ; Xiulan Liu [République populaire de Chine] ; Lin Qiu [République populaire de Chine] ; Dong Liu [République populaire de Chine] ; Juan Li [République populaire de Chine]Hydroxychloroquine treatment in COVID-19: A descriptive observational analysis of 30 cases from a single center in Wuhan, China.
001266 (2020) James J. Dinicolantonio [États-Unis] ; Jorge Barroso-Aranda [Mexique]Harnessing adenosine A2A receptors as a strategy for suppressing the lung inflammation and thrombotic complications of COVID-19: Potential of pentoxifylline and dipyridamole.
001267 (2020) Ruochan Chen [République populaire de Chine] ; Yan Huang [République populaire de Chine] ; Jun Quan [République populaire de Chine] ; Jiao Liu [République populaire de Chine] ; Haichao Wang [États-Unis] ; Timothy R. Billiar [États-Unis] ; Michael T. Lotze [États-Unis] ; Herbert J. Zeh [États-Unis] ; Rui Kang [États-Unis] ; Daolin Tang [États-Unis]HMGB1 as a potential biomarker and therapeutic target for severe COVID-19.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidChloroV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/AbsEn.i -k "importantly" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/AbsEn.i  \
                -Sk "importantly" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    CovidChloroV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    AbsEn.i
   |clé=    importantly
}}

Wicri

This area was generated with Dilib version V0.6.38.
Data generation: Sat May 22 17:02:32 2021. Site generation: Sat May 22 17:06:52 2021